What is the current practice regarding the use of GLP-1 agonists in patients listed for lung transplant and in the post-transplant period?

The current practice regarding GLP-1 RA use is not standardized in the field of lung transplantation. This is mainly due to a lack of adequate data at this point. Various institutions use recommendations from the American Society of Anesthesiologists (ASA) and the American Gastroenterological Associ...

We currently bring all potential recipients on our lung transplant list off GLP-1 agonists prior to listing, and we confirm a normal solid gastric emptying scan at the time of listing, about 1 month after being off the drugs. We have used G: P-1 agonists to facilitate weight loss to our target listi...